---
title: Critical assessment of LC3/GABARAP ligands used for degrader development and
  ligandability of LC3/GABARAP binding pockets
date: '2024-11-25'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39587067/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241126171718&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Recent successes in developing small molecule degraders that act through
  the ubiquitin system have spurred efforts to extend this technology to other mechanisms,
  including the autophagosomal-lysosomal pathway. Therefore, reports of autophagosome
  tethering compounds (ATTECs) have received considerable attention from the drug
  development community. ATTECs are based on the recruitment of targets to LC3/GABARAP,
  a family of ubiquitin-like proteins that presumably bind to the autophagosome ...
disable_comments: true
---
Recent successes in developing small molecule degraders that act through the ubiquitin system have spurred efforts to extend this technology to other mechanisms, including the autophagosomal-lysosomal pathway. Therefore, reports of autophagosome tethering compounds (ATTECs) have received considerable attention from the drug development community. ATTECs are based on the recruitment of targets to LC3/GABARAP, a family of ubiquitin-like proteins that presumably bind to the autophagosome ...